Actively Recruiting
Effectiveness of Balloon Sinuplasty Compared to Placebo in Treating Chronic and Recurrent Maxillary Sinusitis and Its Impact on Eustachian Tube Dysfunction
Led by Tampere University Hospital · Updated on 2022-10-20
120
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the effects of balloon sinuplasty treatment compared to a placebo in adults with chronic or recurrent maxillary sinusitis without nasal polyposis. The study aims to determine how effective balloon sinuplasty is in treating maxillary sinusitis and to identify which patients may benefit most. Additionally, the study investigates whether balloon sinuplasty improves Eustachian tube dysfunction. A total of 120 patients are enrolled, divided equally between chronic and recurrent maxillary sinusitis groups, with random assignment to either balloon sinuplasty or placebo treatment. The treatments are performed under local anesthesia in a day surgery setting. In the balloon sinuplasty group, a flexible balloon device is inserted and inflated in the maxillary sinus ostium to dilate it, while the placebo group undergoes a sham procedure mimicking the balloon inflation without the actual treatment. Both groups have the procedure performed on both maxillary sinuses. The study staff and patients are kept unaware of the treatment assignment to maintain blinding. Patients are followed for 12 months after the operation, with evaluations at 3, 6, 9, and 12 months. Participants complete questionnaires including the Sino-Nasal Outcome Test SNOT-22 and the Eustachian Tube Dysfunction Questionnaire ETDQ-7. Clinical assessments include nasal endoscopy, rhinomanometry, tympanometry, tubomanometry, and Cone Beam Computed Tomography CBCT scans before and after treatment. Biopsies of nasal mucosa are taken during the operation and after 12 months. Researchers also track sinus infection episodes, antibiotic use, sick leaves, and symptom severity using visual scales. The studys primary outcomes focus on changes in quality of life and infection frequency, with safety and effectiveness monitored throughout.
CONDITIONS
Brief Title
Balloon Sinuplasty Efficiency in Maxillary Rhinosinusitis.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 18 to 69 years
- Patients willing to participate in the study
- Patients diagnosed with chronic or recurrent maxillary rhinosinusitis
- Chronic maxillary rhinosinusitis patients must have failed a 3-month trial of topical corticosteroids
- SNOT-22 score of 8 or higher for chronic maxillary rhinosinusitis
- Specific Lund-Mackay score limits in chronic rhinosinusitis as defined
- Recurrent acute maxillary rhinosinusitis patients have no SNOT-22 score limits
You will not qualify if you...
- Chronic rhinosinusitis with nasal polyps
- Significant inflammation in ethmoidal, sphenoidal, or frontal sinuses along with maxillary sinusitis
- Previous nasal surgery
- Presence of sinonasal tumor
- Maxillary rhinosinusitis caused by dental problems
- Facial pain from other causes
- Cystic fibrosis
- Severe immune system problems
- Congenital mucociliary disorders
- Fungal sinus infections (non-invasive or invasive)
- Systemic vasculitis or granulomatous diseases
- Severe systemic diseases
- Cancer
- Pregnancy
Research Team
J
Johanna Luukkanen
M
Markus Rautiainen
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here